RE:RE:All you can buy!!!Davepark5
I need this baby to rocket up too. One thing at the time.
General market sentiment was very negative that is check off now.
Timing a rocket is difficult. Multiple possible launches... but so far so good.
From now until Asco should be the window. I am going to be patient.
This remains the best opportunity for something going parabolic.
If not I still will make a decent return...
Again GOBLET was just interim data (complete response). They got accelerated approval based on interim results.
Same for ADLAI interim data - but we can see 9.4 months of life as per september vs. 10.5 baseline
So very very promissing. I think the market is still not giving full credit to ONCY because both of these trial are interim data contrary to the other biotech that was mentionned here that got completed trial data.